Skip to content

Public FDA record

Z-0722-03: CryoValve Heart-valve, allograft

Recall record Z-0722-03 for Cryolife Inc. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-0722-03
Company in FDA record
Cryolife Inc
FDA classification date
Apr 15, 2003
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Unknown — no matched enforcement classification

Reason stated in the source

The recipient of one of the kidneys from the donor has developed renal cell carcinoma.

Source facts

Action
Implanting physicians were notified by letter on 3/19/2003. Since CryoLife has been notified that the allografts have been implanted, the notification is intended to provide the physician with a basis to determine if any additional patient surveillance or intervention is necessary. They were advised to complete an enclosed, stamped, self-addressed postcard to affirm receipt of the notification.
Initiated
2003-03-19
Root cause
Other
Terminated
2003-05-05
Distribution
Allografts were distributed to 2 physicians in NY and MS. Allografts were implanted.
Recall number
Z-0722-03
Recall status
Terminated
CDRH record ID
26556
FDA classified
2003-04-15
Recall event number
25832

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗